Видео ютуба по тегу Rna Adjuvant

RNA-based Drugs Including Delivery of Antibodies and Vaccines Using mRNA
RNA-based Drugs Including Delivery of Antibodies and Vaccines Using mRNA
Nucleic Acid Vaccines: The Beginning of a Medical Revolution
Nucleic Acid Vaccines: The Beginning of a Medical Revolution
Prof. Ken Ishii: Vaccine science and adjuvant design by nucleic acids
Prof. Ken Ishii: Vaccine science and adjuvant design by nucleic acids
Advances in mRNA Vaccine Therapies Dr. Yvonne Perrie
Advances in mRNA Vaccine Therapies Dr. Yvonne Perrie
ABCF | Development of RNA- Based Vaccines in Breast Cancer Educational Program
ABCF | Development of RNA- Based Vaccines in Breast Cancer Educational Program
GMP Manufacturing of Messenger RNA Therapeutics and Vaccines: Case Study of a SA SARS CoV-2 Vaccine
GMP Manufacturing of Messenger RNA Therapeutics and Vaccines: Case Study of a SA SARS CoV-2 Vaccine
Adjuvant Treatments and Systemic Therapy for nccRCC
Adjuvant Treatments and Systemic Therapy for nccRCC
Ask the Expert – Vaccinations
Ask the Expert – Vaccinations
mRNA Applications
mRNA Applications
RNA Nanomedicines for Individualized Tumor Immunotherapy...
RNA Nanomedicines for Individualized Tumor Immunotherapy...
AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey Weber
AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey Weber
Emerging Diagnostic Technologies in GI Cancer: 2023 Best of GI
Emerging Diagnostic Technologies in GI Cancer: 2023 Best of GI
INTerpath-005: V940, an mRNA-based therapy, and pembrolizumab in MIBC
INTerpath-005: V940, an mRNA-based therapy, and pembrolizumab in MIBC
Персонализированная мРНК-вакцина против меланомы | Обновленная информация по иммунотерапии для ст...
Персонализированная мРНК-вакцина против меланомы | Обновленная информация по иммунотерапии для ст...
Multi-Valent DNA Vaccines Encoding Coccidioides Proteins and Potent Genetic Adjuvants
Multi-Valent DNA Vaccines Encoding Coccidioides Proteins and Potent Genetic Adjuvants
Circular RNA Immunity
Circular RNA Immunity
Innate Immunity, Nucleic Acid Immune Sensing Receptors, Part 1: CpG DNA TLR9 HBV vaccine adjuvants
Innate Immunity, Nucleic Acid Immune Sensing Receptors, Part 1: CpG DNA TLR9 HBV vaccine adjuvants
Phase II trial of BNT111 and cemiplimab in PD-1–refractory melanoma
Phase II trial of BNT111 and cemiplimab in PD-1–refractory melanoma
Karine Breckpot, PhD | Leveraging mRNA Technology Workshop 2023
Karine Breckpot, PhD | Leveraging mRNA Technology Workshop 2023
Emerging neoadjuvant therapies for metastatic melanoma at ESMO 2024
Emerging neoadjuvant therapies for metastatic melanoma at ESMO 2024
Day 3 - Biomarkers from the BILCAP series focus on HER2 1080p
Day 3 - Biomarkers from the BILCAP series focus on HER2 1080p
MATADOR: immune gene profiles in tailoring breast cancer treatment
MATADOR: immune gene profiles in tailoring breast cancer treatment
mRNA Manufacturing
mRNA Manufacturing
Modern Vaccine and Adjuvant Production and Characterization
Modern Vaccine and Adjuvant Production and Characterization
Are gene signatures ready for use in the selection of patients for adjuvant treatment?
Are gene signatures ready for use in the selection of patients for adjuvant treatment?